Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Immuno Oncology 2020

ABOUT THE CONFERENCE:

We extend our hearty welcome to all the participants to IMMUNO ONCOLOGY 2020 scheduled on November 16-17, 2020 at Singapore City, Singapore with a theme “Quantum leap on Cancer Science &Oncology ". We organize Global Events with Conferences, Symposiums and Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

               We gladly welcome all the attendees around the world for the hearing of the foremost recent innovations and inventions in the field of cancer. This Conference will provide a place for the exchange of ideas and views by leading scientists, researchers and also from the academicians around the globe. There will be many outstanding keynote speakers and well known leading scientists and experts from various places of the globe to share their ideas and talk about various aspects related to the field of Cancer. Our aim is to gather peer researchers, young scientists, academicians & industrialists to meet, discuss and share the ideas related to it and the knowledge that’s still more to be revealed. We heartily encourage you to attend and contribute to one of the major events of 2020 in the field of Cancer stem cells. The conference will reveal the present and future aspects in the field of Cancer stem cell which are the need for instant and better treatment.

 

 Who and Why??

 

IMMUNO ONCOLOGY CONFERENCE – 2020 Conference brings together the specialists from all the aspects to discuss about the future of Oncology and Cancer in today’s world to thrive and survive with a better health. Directors specialists, Investigators, Post-Doctoral Fellows, Research and Diagnostic Laboratories, Clinical Fellows, Students, Biomedical Research companies, Healthcare Institutions, Market Research and Consulting Firms, Pharmaceutical Companies and all other interested participants willing to enhance and update the knowledge may attend the conference.

 

Cancer Science & Oncology:

 

The branch of health care that determines the safety & efficacy of medications, devices, and diagnostics and also treatments intended for human use is termed  Clinical Research .These are used for the treatment , prevention, diagnosis and relieving symptoms of the diseases. Clinical research may differ from clinical practice. Clinical Practice uses established process , whereas in case of clinical research evidence is collected for establishing the new treatment using “biological marker” .i.e. Biomarker refers to the category of medical signs or say objective indications of the medical state which is observed from outside the patient – and is measured accurately.

 

ABOUT CITY

Singapore officially the Republic of Singapore, is a sovereign island city-state in Southeast Asia. It lies off the southern tip of the Malay Peninsula and is 137 kilometres (85 m) north of the equator. There are also numerous famous attractions within the city-state, notably Gardens by the Bay, Sentosa Island, Jewel Changi Airport, Marina Bay Sands, Orchard Road  and the Singapore Zoo, which was ranked the best zoo in Asia. 

During the Second World War, Singapore was occupied by Japan, Singapore gained independence from the British Empire in 1963 by joining Malaysia along with Sabah and Sarawak. Singapore is a highly developed country and is ranked 9th on the UN Human Development Index, With the 2nd highest GDP per capita in the world the highest in Asia for a sovereign state.

In the 1960s, the city-state of Singapore was an undeveloped country with a GDP per capita of less than U.S. $320. Today, it is one of the world's fastest-growing economies. Singapore's economic ascension is nothing short of remarkable. By embracing globalization, education, and pragmatic policies, free-market capitalism it has been able to overcome its geographic disadvantages and become a leader in global commerce.

Independence                                                                                                                              

For over 100 years, the Singapore was under the British control. But when the British failed to protect the colony from the Japanese during World War II, it sparked a strong anti-colonial and nationalist sentiment that subsequently led to Singapore's independence.

The Chinese in Singapore outnumbered the Malay three-to-one. As a way of ensuring a Malay majority within Malaysia proper and to limit the influence of communism, the Malaysian parliament voted to expel Singapore from Malaysia. Singapore gained formal independence on August 9, 1965, with Yusof bin Ishak serving as its first president and  Lee Kuan Yew as its prime minister.

After independence, Singapore continued to experience problems. They became unfriendly states in Malaysia and Indonesia. Singapore lacked natural resources, proper infrastructure, adequate water supply and sanitation.

Globalization

Singapore's economy was centered on entrepôt trade during colonial times. It is influenced by Israel's ability to leap over its Arab neighbors (who boycotted Israel) and trade with Europe and America, Lee and his colleagues knew they had to connect with the developed world and to convince multinational corporations to manufacture in Singapore.

Singapore had to create an environment that was safe, corruption-free, and low in taxation in order to attract investors. Lee's People Action Party (PAP) repressed all independent labor unions and consolidated what remained into a single umbrella group called the National Trade Union Congress (NTUC), which the party directly controlled.

By 1972, just seven years after independence, one-quarter of Singapore's manufacturing firms were either foreign-owned or joint-venture companies, and both the United States and Japan were major investors.

As a result, favorable investment conditions and the rapid expansion of the world economy from 1965 to 1972, the country's Gross Domestic Product (GDP) experienced annual double-digit growth. By the 1990s, they were engaging in wafer fabrication, logistics, biotech research, pharmaceuticals, integrated circuit design, and aerospace engineering.

A Modern Economy

The Port of Singapore is now the world's busiest transhipment port, surpassing Hong Kong and Rotterdam. It has become the world's second busiest in terms of total cargo tonnage handled.

Banking has grown significantly in recent years and many assets formerly held in Switzerland have been moved to Singapore due to new taxes imposed by the Swiss. The biotech industry is burgeoning, with drug makers such as GlaxoSmithKline, Pfizer, and Merck & Co.

Singapore is now the 15th largest trading partner of the United States. With a total land area of just 433 square miles and a small labor people of 3 million, Singapore is able to produce a GDP that exceeds $300 billion dollars annually. Life expectancy is 83.75 years, the third highest in the world.

 

 

SESSIONS AND TRACKS

Track 1: Cancer Stem Cell

Cancer Stem Cell (CSC) hypothesizes the presence of a little populace of diseased cells with characteristic properties like protection from traditional radio-chemotherapy regiments and increased metastatic potential. Clinically, the forceful idea of CSCs has been appeared to connect with expanded tumour repeat, metastatic spread, and generally very low patient result over various malignant growth subtypes. Separation of CSC’s has been achieved through the use of cell surface markers by the useful contrasts among CSCs and remaining tumour cells have been portrayed through expansion, separation, and constraining weakening measures.

Embryonic Stem Cell

Epigenetics     

Stem Cell Therapy

Stem Cell Transplantation

 

Track 2: Oncology Research

 

Oncology is a part of the medication that bargains with the anticipation, conclusion, and treatment of Cancer disease. Survival has been enhanced because of three primary segments including enhanced counteractive action endeavours to diminish presentation to chance elements (e.g., tobacco smoking and liquor utilization) enhanced screening of a few tumours (taking into consideration prior finding), and upgrades in treatment.

 

Malignant growths are regularly overseen through discourse on multi-disciplinary disease gatherings where radiation oncologists, pathologists, radiologists, and organ particular oncologists meet to locate the most ideal administration for an individual patient considering the physical, social, mental, and money related status of the patient. It is vital for oncologists to keep refreshed as for the most recent headways in oncology, as changes in administration of malignancy are very normal.

 

Immuno Oncology

Nursing Oncology

Cancer Science

Oncogenes

Abnormal Cell growth

Tumours

 

Track 3: Oncology Research Categories

Cancer Oncology examines are being led remembering different classes or criteria like area, influenced organ, sort of Cancer disease, kind of consideration or drug, condition or encompassing.

 

Medical oncology

Radiation Oncology

Surgical Oncology

Clinical Oncology

Paediatric Oncology

 

Track 4: Stem cells

Stem Cells are Biological cells that can separate into different sorts of cells and can divide to deliver same kind of cells in huge numbers. They are found in multicellular life forms. In mammals, there are two wide kinds of stem cells: embryonic stem cells, which are isolated from the internal cell mass of blastocysts, and adult stem cells, which are found in different tissues.

 Neural Stem Cells

Stem cell in Organ Transplantation

Tissue Regeneration

Research in Stem Cell

Cancer cure using Stem Cell

 

Track 5: Bio-markers of Cancer Stem Cells

 

Liver cancer is the fifth most analysed and the second most ceaseless reason for cancer death in men around the world. Amongst liver cancers, hepatocellular carcinoma (HCC) represents the major histological subtype and it is one of the most common malignant human tumours. Research into the molecular biology of hepato-carcinogenesis has identified several biomarkers, which could provide additional information in order to better understand the biology of HCC. A large number of biomarkers have been shown to have probable predictive significance and a wide variety of molecular markers have been proven to be excellent diagnostic tools for HCC however it is hard to represent HCC with a single biomarker. Therefore, marks of a mix of biomarkers might be more important for the finding, arranging and visualization of HCC. Specifically, a correlation of HCC-CSCs phenotype to specific hepatic cancer subtypes and to specific clinical and pathological features has not yet been reported in human liver tumours.

RAPD

Transciptomic Biomarkers

Proteomic Biomarkers

RFLP

Track 6: Immunology

Immunology is a part of science that covers the study of immune systems in all living beings. Immunology outlines, measures, and contextualizes the physiological working of the immune system in conditions of both wellbeing and sicknesses; breakdowns of the immune system in immunological disorders , example : autoimmune diseases,, hypersensitivities  immune deficiency, and rejection of transplants: the physical, compound and physiological attributes of the segments of the  immune system in vitro, in situ, and in vivo. Immunology has applications in various orders of medication, especially in the fields of organ transplantation, oncology, rheumatology, virology, bacteriology, parasitology, psychiatry, and dermatology.

Pluripotent Stem Cells           

Haemopoetic Stem Cell

Stem Cell Niche

Mesenchymal Stem Cell

Molecular Signalling

 

Track 7: Cancer Stem Cell Treatments

Cancer treatments against tumour, chemo-and radiotherapy, have various restrictions that prompt treatment disappointment and disease repeat. These cells are associated with tumour formation, support, metastasis and repeat. Consequently, with the end goal to create productive medicines that can prompt a dependable clinical reaction forestalling tumour backslide it is vital to create drugs that can particularly target and dispose of CSCs. On-going distinguishing proof of surface markers and comprehension of atomic element is related with CSC phenotype, assisted with the plan of viable medicines

Gene Treatment

Epigenic Alternatives

Radiation Treatments

 

Track 8: Types of Cancer

Cancer types include Carcinoma, Sarcoma, tumours got from epithelial cells. This gathering incorporates a large number of the most widely recognized malignancies and incorporate almost each one of those in the bosom, prostate, lung, pancreas and colon.

Bladder Cancer

Breast Cancer

Colon and Rectal Cancer

Endometrial Cancer

Kidney Cancer

Leukaemia

Liver Lung Cancer

Melanoma

Non-Hodgkin Lymphoma

Pancreatic Cancer

Prostate Cancer

Thyroid Cancer

 

Track 9: Nanotechnology in Cancer

 

Cancer nanotechnology is a part of nanotechnology which deals with various techniques, equipment’s also known as Nano-materials to the analysis and treatment of cancer. It is the branch of nanotechnology that uses Nano-science and Nano vectors to cure or stop cancer cells and their growth

Cancer Treatment

Immunotherapy

Nanotechnology in Cancer Cure

 

Track 10: Cancer Stages

Organizing can be "clinical" or "neurotic." Clinical organizing is based on the after effects of the tests done prior to the medical procedure for example:  physical examinations and imaging filters. Neurotic organizing based on what is found through the medical procedure. Clinical stage is regularly demonstrated by a lowercase "c" before the TNM grouping. The obsessive stage is demonstrated by a lowercase "p."

TNM framework organizing

Post Therapy

Recurrence

Autopsy

 

Track 11: Cancer Causes

There can be more than one reason for cancer cells formation and growth. Various powers can cause quality changes, for example, smoking, radiation, infections, Cancer causing synthetic compounds (cancer-causing agents), heftiness, hormones, endless aggravation and an absence of activity.

Hereditary Malignancies

Radiation effect

Lifestyle effects

 

 Track 12: Cancer Treatment

The causes for cancer may differ from genetic to the lifestyle of an individual. Cancer can spread from one region of the body to another and can also lead to death, there are some ways to treat or to reduce the spread of it.

Chemotherapy

Immunotherapy

Hormonal Treatment

Use of Inhibitors

Photodynamic Treatment

 

 

Track 13: Cancer prevention

Cancer Prevention contains steps that are taken to bring down the danger of getting the Cancer disease. This can incorporate keeping up a solid way of life, to know disease causing substances, and taking prescriptions or immunizations that can keep cancer from formation.

Proper and Healthy Diet

Medication

Change in Lifestyle

 

Track 14: Clinical research and trials in stem cells and cancer

Clinical preliminaries are broadly observed for real advances in Cancer treatment because of developing new medications to avert or help oversee Graft-Versus-Host Disease (GvHD). Graft-Versus-Host Disease a typical and conceivably extreme reaction of stem cell transplants in which contributor safe cells attack solid patient cells and tissues. Creating cancer immunization systems for use alongside transplant to invigorate the Graft-Versus- leukaemia (GVL) impact and limit malady backslide. Graft-versus-Leukaemia has restorative impact in which transplanted invulnerable cells attack leftover leukaemia or other tumour cells

Cellular therapy

Tissue regeneration

Drug discovery

Stem Cell Transplantation

 

 

Track 15: Bioinformatics and Systems Biology

Bioinformatics and System Biology utilize PC techniques to investigate the natural information. As opposed to the past attention on single qualities or proteins, frameworks science is a field of research which focuses on understanding whole natural frameworks, for example: protein buildings, metabolic pathways, or quality administrative systems.

Molecules and Cells

Genes, Systems, and Evolution

Statistics in Biology

Applied Genomics

Programming for Biologists

Biological Databases and Data mining

Bioinformatics and Evolutionary Genomics

 

Track 16: 3D Bio printing & Bio fabrication

Bio fabrication is alluded to the generation of fake tissues or organs to address wellbeing challenges in medication. It frequently utilizes the rule of 3D Bio printing to shape cells, gels and strands into an organ.

Bioprinting using microfluidics

Bio inks

Engineered Tissue

3D printing technologies

Innovative development in 3D-bioprinting

Intelligent bio materials

 

 

Track 17: Gene therapy

Gene Therapy is an exploratory strategy that utilizes qualities to treat or anticipate ailment. Later on, this strategy may enable specialists to treat confusion by embedding a quality into a patient's cells as opposed to utilizing medications or medical procedure. In spite of the fact that gene therapy is a promising treatment alternative for various ailments (counting acquired disarranges, a few sorts of malignancy, and certain viral contaminations), the system stays hazardous is still under examination to ensure that it will be protected and successful. Gene Therapy is as of now being tried just for maladies that have no different fixes

Macular Degeneration

Utero CRISPR

Metabolic liver disease

CRISPR–Cas9 genome-wide nuclease

Streptococcus pyogenic

Immunoglobulin therapy for Kawasaki disease

 

 

Track 18: Stem Cell Biology and advances

Most of the structural microorganisms have the astonishing potential to form into a wide range of cell types, basically unlimited to renew different cells until the individual is alive, offering any expectation of relieving Alzheimer's disease , treating kidney, liver and lung diseases . Until today, researchers principally worked with two types of undistinguishable organisms from creatures and people that are embryonic foundational microorganisms and non-embryonic "physical" or "grown-up" undeveloped cells. Late leap forward make it conceivable to change over or "reconstruct" specific grown-up cells to expect a stem cell with various improvements. The audit will quickly talk about the on-going developments here.

Stem cells in endocrinology

Liver stem cells and regeneration

Early embryonic development

 

Neural stem cells and regeneration

Blood stem cells and regeneration

Muscle (cardiac and skeletal) stem cells and regeneration

Totipotency, pluripotency and multipotency

 

 

Track 19: Advanced in Tissue Regeneration

Tissue Engineering is a logical field and depicted as understanding the benchmarks of tissue and its improvement by handy exchange of insufficient tissue for clinical use. Tissue building deals about the investigation of mixing of cells, structuring, materials and methodologies, biochemical segments to upgrade characteristic tissues. It includes the utilization of Scaffolds to shape practical tissues and organs, which can be embedded, again into the benefactor, have with the utilization of many building and materials techniques alongside some hemispherical elements. It is recognized with in excess of one branch which applies building information and life science ideas towards the advancement of natural substitutes which can enhance or re-establish all the qualities of an organ.

Tissue Engineering

Regenerative Medicine

Bio Materials

Scaffolds

Tissue Regeneration

 

Track 20: Umbilical Cord Stem Cells

Moral and logical issues encompass both embryonic and fatal Cord Stem cells and frustrate their across the board usage. Interestingly, foundation microorganisms recuperated postnatal from the umbilical line, including the umbilical string platelets, amnion/placenta, umbilical rope vein, or umbilical string lattice cells, are a promptly accessible and modest wellspring of cells that are fit for framing a wide range of cell types (i.e., they are "multi-potent"). This survey will centre around the umbilical rope determined immature microorganisms and contrast those cells and grown-up bone marrow-inferred melancholy undifferentiated organisms.

Corneal disease

Umbilical cord blood transplant.

 

          

Track 21: Stem Cell and Tissue Homeostasis

Tissue homeostasis depends upon the precise direction of substantial foundational microorganism movement. Substantial undeveloped cells need to react to tissue and therefore harm and multiply as per tissue requirements, while staying away from over-multiplication. The administrative systems engaged with these reactions are presently being separated in the intestinal epithelium of Philosophical, giving new understanding into procedures and components of undeveloped cell direction in obstruction epithelial.

Stem cells and their niches

Hematopoietic stem cells

Stem cells and the origin of intestinal cancer

 

 

 

Track 22: Stem Cell Aging

Maturing tissues encounter a dynamic decrease in homeostatic and regenerative limits, which has been credited to degenerative changes in tissue-particular foundation microorganisms, undifferentiated organism specialties and fundamental signals that manage undeveloped cell action. Understanding the sub-atomic pathways associated with this age-subordinate crumbling of immature microorganism capacity will be basic for growing new treatments for maladies of maturing that objective the particular reasons for age-related utilitarian decay. Here we investigate key sub-atomic pathways that are generally irritated as tissues and undifferentiated organisms age and savage.

Theories of aging

Theories of biological aging

Proximate theories of biological aging

Alzheimer‘s disease

Cardiovascular diseases

 

Track 23: Stem Cell Therapy

Essential microorganisms are the body's rough materials cells from which each other cell with particular boundaries are created. New stem cells either end up being new undifferentiated cells with a more specific limit for instance: platelets, mind cells, heart muscle cells or bone cells. No other cell in the body has the featured ability to make new cell types.

Acute Lymphoblastic Leukaemia

Acute Megakaryocytic Leukaemia

Acute Myelomonocytic Leukaemia

Lymphoma Cancer

Immune Cell Therapy

Allogeneic transplantation.

Advances in Bone Marrow Stem Cell

 

 

Track 24: Recent advances in Stem Cell

All the immature microorganisms possess an amazing potential to form into various cell types, basically unbounded to renew different cells as long as the individual is alive, thus offering monstrous any desire for relieving Alzheimer's ailment, fixing harmed spinal lines, treating kidney, liver and lung sicknesses. Until today, researchers essentially worked with two sorts of undeveloped cells from creatures and people: embryonic undifferentiated cells and non-embryonic "substantial" micro-organisms. On-going achievement makes it conceivable to change over or "re-invent" specific grown-up cells to expect stem-like cells with various advancements. The survey will quickly talk about the on-going advances here.

Embryonic stem cells

Somatic cell nuclear transfer (SCNT)

Induced pluripotent stem cell (iPSC)

Stimulus-triggered acquisition of pluripotency (STAP)

Adult Stem Cells

Adult Neural Stem Cells

 

Track 25: Epidermal Stem Cells

The skin continually re-establishes itself for the duration of grown-up life, and the hair follicle experiences an interminable cycle of development and degeneration.   Microorganisms (Stem cells) dwelling in the epidermis and hair follicle guarantee the support of grown-up skin homeostasis and hair recovery, however they likewise take part in the fixation of the epidermis after wounds.

Stem cells with in adult skin epithelium

Signalling and stem cell fate specification in the skin

Bone Morphogenetic Protein Signalling

Notch Signalling

 

Track 26: Stem Cell Renewal

In numerous tissues, mammalian maturing is linked with a decrease in the replicative and effective limit of physical immature microorganisms and other self-recharging compartments. Therefore understanding the premise of this decay is a noteworthy objective of maturing research. . Such methodologies incorporate accomplishments to shield undifferentiated organisms from age-advancing harm, to 'revive' foundation microorganisms using pharmacologic specialists that moderate maturing impelled modifications in flagging, and to replace lost undeveloped cells through regenerative drug approaches. Some progress has been made in every one of these fields in the course of the most recent year and a half incorporating advances in the generation of contributor particular supreme undifferentiated organisms through prompted diplomat, gains in our command of how tumour silencer flagging is controlled in self-restoring compartments to direct maturing, and further show of extracellular 'milieu' factors that bother undeveloped cell work with age.

Regenerative medicine and iPS    

Somatic self-renewal and aging

somatic stem and progenitor cell aging

 

Track 27: Ethics considerations in stem cell therapy

Stem Cell Research offers incredible guarantee for understanding fundamental elements of human advancement and separation, additionally the expectation for new medications for illnesses, for example, diabetes, spinal line damage, Parkinson's ailment, and myocardial localized necrosis. In any case, human Stem Cell inquires about additionally raises sharp moral and political contentions. The reconstructing of substantial cells to deliver instigated pluripotent undifferentiated organisms keeps away from the moral issues particular to embryonic microorganism examine. In any hSC look into, be that as it may, troublesome problems emerge with respect to delicate downstream research, agree to give materials for hSC explore, early clinical preliminaries of hSC treatments, and oversight of hSC inquire about. These moral and strategy issues should be talked about alongside logical difficulties to guarantee that undeveloped cell examine is done in a morally suitable way. This article gives a basic investigation of these issues and how they are tended to in current approaches

Multi-potent Stem Cells

Embryonic Stem Cell Research

Somatic Cell Nuclear Transfer

Induced Pluripotent Stem Cells Stem Cell Clinical Trials

 

 

Track 28: Advances in developmental biology and stem cells

Developmental biology is proposed as "the stem cell of biological disciplines." Genetics, cell science, oncology, immunology, transformative components, neurobiology, and frameworks science has its heritage in formative science. Formative science keeps on moving on, while holding its very own character. While its relative controls separate into sciences with a limited arrangement of standards, precedents, and systems, formative science stays incredible, pluripotent, and generally undifferentiated. In numerous orders, particularly in transformative science and oncology the developmental point of view is being reaffirmed as a critical research program.

 

Tissue compartmentalisation

Oncogenic perturbation of stem cell behaviour

Compartmentalisation and heterogeneity beyond the epidermis

 

MARKET ANALYSIS

We invite all the participants throughout the globe to join at the Conference on Cancer Science & Oncology which is going to be held during Nov 16-17, 2020, Singapore city which will include, Oral talks, keynote presentations, Poster presentations, and Exhibitions. Immuno Oncology 2020 is a specially planned group conference. The core theme of the conference is “Quantum leap on Cancer Science &Oncology” which covers a wide range of important sessions.

MARKET ANALYSIS OF CANCER:

 

The global stem cells market extent was estimated at USD 8.65 billion in the year 2018 and is expected to expand at a CAGR of 8.8% over the predicted period. According to the Wide Cells Group, between the years 2005 and 2013, there has been a 300% rise in the number of diseases that can be cured by stem cells.

Stem Cell Therapy Market revenue will reach $15 billion by 2025. Oncology segment held over 39% revenue in 2019. The global stem cell therapy market is expected to witness a CAGR of 10.6% during the forecast period 2019-2024, and is also predicted to reach USD 214.5 million by the end of 2024.

 

Importance & Scope

 

Cancer is second leading cause of death worldwide. Treatments that work for some cancers don’t work for the others and sometimes those treatments simply stop working and only a global search for answers will help us get to grip this disease. The conference will provide with an opportunity for the delegates from Universities and Institutes to interact with the world class Scientists and Industry Professionals working in the field of oncology.

 

Immuno Oncology 2020 will also explore the new ideas and concepts on global scale and the topics Cancer Science & Therapy, Cancer Cell Biology, Organ-Defined Cancers, Tumour Science, Cancer Genetics, Clinical Cancer Research, Cancer & Tumour Immunology, Cancer : Genomics & Metabolomics, Targeted Cancer Therapy, Stem Cell Therapy, Cancer Biomarkers, Cancer Nanotechnology, Cancer Treatment and Therapeutics, Cancer Clinical Trials, Cancer Case Reports, Cancer Drug Diagnostics & Therapeutics, Precision Medicine & Cancer Therapy, Cancer Management & Prevention, Economic Impact of Cancer Therapy.

 

Market Analysis Report:

 

Cancer is a disease categorized by the uncontrolled growth and spread of abnormal cells. If the growth of these cells is not controlled, it can result in death. Cancer has more mortality rate than AIDS, tuberculosis and malaria. Based upon the income when countries are grouped, cancer is the second leading cause of death in high-income countries and the third leading cause of death in low- and middle-income countries.

Cancer Diagnostic Market:

 By Technology:

  1. Platform Based:

In situ Hybridization

Flow Cytometry

Next-generation Sequencing

Microarrays

Others

 

B. Instrument Based:

Mammography

Biopsy

PET

Ultrasound

MRI

CT

 

Cancer Diagnostic Market:

By Region:

 

Based on region, the cancer diagnostics market is classified into North America, Europe, Asia, and Rest of the World. Rest of the World includes Latin America, Pacific countries, and Middle East and Africa. North America is predicted as the largest share in the cancer diagnostics market, followed by Europe and Asia.

 

List of the major performers in the cancer diagnostics system market globally are:

 

  • Sanofi (France)
  • Novartis (Germany)
  • Pfizer Inc. (U.S.)
  • Eli Lilly & Company (U.S.)
  • ImClone Systems Inc. (U.S.)
  • GlaxoSmithKline (U.K)
  • AstraZeneca (U.K)
  • Schering-Plough (U.S.)
  • Boehringer Ingelheim (Germany)
  • Bristol-Myers Squibb
  • Teva Pharmaceuticals Industries (Japan)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Merck & Co., Inc. (U.S.)
  • Chemo Espana SL (Spain)
  • CELGENE CORPORATION (U.S.)
  • Amgen Inc (U.S.)
  • Bayer AG (Germany)
  • Takeda Pharmaceutical Company Limited (Japan)

 

 

List of Associations Worldwide:

 

  • American Association for Cancer Research
  • Virginia Cancer Institute
  • American Brain Tumor Association
  • American Society of Paediatric Haematology/Oncology
  • Association of Cancer Physicians
  • American Childhood Cancer Organization
  • American Society of Clinical Oncology
  • Australasian Lung Cancer Trials Group
  • International Cancer Research Partnership (ICRP)
  • American Association for Cancer Research (AACR)
  • American Society of Clinical Oncology (ASCO)
  • International Agency for Research on Cancer (IARC)
  • Cancer Society of New Zealand
  • Irish Cancer Society
  • Australian Cervical Cancer Foundation
  • Medical Centre Cologne
  • Cancer Research UK
  • Australian Prostate Cancer Research
  • Peter McCollum Cancer Centre
  • The European Cancer Organization (ECCO)
  • German Cancer Research Centre

 

 

List of Medical Universities worldwide:

 

  • Harvard University
  • University of Minnesota
  • Mayo Medical School
  • Pittsburgh School of Medicine
  • Yale University
  • University of Cambridge
  • University of Oxford Stanford University
  • Yale University
  • Emory University
  • John Hopkins University
  • Kings College London
  • Feinberg School of Medicine
  • University of Wisconsin
  • UNC School of Medicine
  • Karolinska University

 

    

Cancer related companies:

Roche | Sanofi | Johnson & Johnson | Merck & Co. (MSD) | Novartis | AbbVie | Gilead Sciences | GlaxoSmithKline (GSK) | Amgen | Pfizer | F. Hoffmann-La Roche Ltd | Celgene Corp | Novartis AG | Bristol-Myers Squibb Co | Samsung Medical Centre

 

To Collaborate Scientific Professionals around the World

Conference Date November 16-17, 2020

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Supported By

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by